| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | Feb 7, 2025 | Tyra Biosciences, Inc. | Director | Sell | 47.5 | -5,401 | -0.13% | ✗ | $74.3K |
| Jan 23, 2025 | Jan 27, 2025 | Tyra Biosciences, Inc. | Director | Sell | 47.5 | -4,825 | -0.12% | ✗ | $78.5K |
| Jan 16, 2025 | Jan 21, 2025 | Tyra Biosciences, Inc. | Director | Sell | 37.5 | -25,041 | -0.32% | ✗ | $409.6K |
| Nov 25, 2024 | Nov 26, 2024 | Tyra Biosciences, Inc. | Director | Sell | 47.5 | -5,272 | -0.13% | ✗ | $88.8K |
| Nov 6, 2024 | Nov 8, 2024 | Tyra Biosciences, Inc. | Director | Sell | 17.5 | -74,582 | -1.75% | ✗ | $1.3M |
| Nov 4, 2024 | Nov 6, 2024 | Tyra Biosciences, Inc. | Director | Sell | 40.0 | -11,569 | -0.27% | ✗ | $194.2K |
| Oct 30, 2024 | Nov 1, 2024 | Tyra Biosciences, Inc. | Director | Sell | 17.5 | -138,711 | -1.69% | ✗ | $2.3M |
| Apr 20, 2015 | Apr 22, 2015 | Cidara Therapeutics, Inc. | Director | Buy | 100.0 | +200,000 | 100.00% | ✗ | $3.2M |
| Apr 14, 2015 | Apr 14, 2015 | KalVista Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +810,000 | 21.26% | ✗ | $4.1M |